504 related articles for article (PubMed ID: 12004148)
1. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
[TBL] [Abstract][Full Text] [Related]
2. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
[TBL] [Abstract][Full Text] [Related]
3. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
4. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
[TBL] [Abstract][Full Text] [Related]
5. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
7. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
8. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
10. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
[TBL] [Abstract][Full Text] [Related]
12. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
[TBL] [Abstract][Full Text] [Related]
13. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
14. Chemoreduction in the management of retinoblastoma.
Shields JA; Shields CL; Meadows AT
Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
[No Abstract] [Full Text] [Related]
15. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
17. [Conservative treatment in patients with unilateral retinoblastoma].
Rutynowska-Pronicka O; Hautz W; Brozyna A; Dembowska-Bagińska B; Drogosiewicz M; Stypińska M; Perek D
Med Wieku Rozwoj; 2006; 10(3 Pt 1):655-63. PubMed ID: 17317897
[TBL] [Abstract][Full Text] [Related]
18. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
19. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
20. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
